ALNY

#336
Alnylam Pharmaceuticals, Inc.
339.41 USD
+1.92%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
339.41
339.41
Rango anual
225.84
495.55
Cambio diario
+1.92%
Variación mensual
+9.06%
Variación en los últimos 6 meses
-27.66%
Cambio anual
+41.50%
Cierres anteriores
333.00
Abrir
339.41
Bid
Ask
Mínimo
339.41
High
339.41
Volumen
197
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Noticias